Gialluisi, A.* ; Andlauer, T.F.M.* ; Mirza-Schreiber, N. ; Moll, K.* ; Becker, J.* ; Hoffmann, P.* ; Ludwig, K.U.* ; Czamara, D.* ; Pourcain, B.S.* ; Honbolygó, F.* ; Tóth, D.* ; Csépe, V.* ; Huguet, G.* ; Chaix, Y.* ; Iannuzzi, S.* ; Demonet, J.F.* ; Morris, A.P.* ; Hulslander, J.* ; Willcutt, E.G.* ; DeFries, J.C.* ; Olson, R.K.* ; Smith, S.D.* ; Pennington, B.F.* ; Vaessen, A.* ; Maurer, U.* ; Lyytinen, H.* ; Peyrard-Janvid, M.* ; Leppänen, P.H.T.* ; Brandeis, D.* ; Bonte, M.* ; Stein, J.F.* ; Talcott, J.B.* ; Fauchereau, F.* ; Wilcke, A.* ; Kirsten, H.* ; Müller, B.* ; Francks, C.* ; Bourgeron, T.* ; Monaco, A.P.* ; Ramus, F.* ; Landerl, K.* ; Kere, J.* ; Scerri, T.S.* ; Paracchini, S.* ; Fisher, S.E.* ; Schumacher, J.* ; Nöthen, M.M.* ; Müller-Myhsok, B.* ; Schulte-Körne, G.*
Genome-wide association study reveals new insights into the heritability and genetic correlates of developmental dyslexia.
Mol. Psychiatry 26, 3004–3017 (2021)
Developmental dyslexia (DD) is a learning disorder affecting the ability to read, with a heritability of 40-60%. A notable part of this heritability remains unexplained, and large genetic studies are warranted to identify new susceptibility genes and clarify the genetic bases of dyslexia. We carried out a genome-wide association study (GWAS) on 2274 dyslexia cases and 6272 controls, testing associations at the single variant, gene, and pathway level, and estimating heritability using single-nucleotide polymorphism (SNP) data. We also calculated polygenic scores (PGSs) based on large-scale GWAS data for different neuropsychiatric disorders and cortical brain measures, educational attainment, and fluid intelligence, testing them for association with dyslexia status in our sample. We observed statistically significant (p < 2.8 x 10(-6)) enrichment of associations at the gene level, forLOC388780(20p13; uncharacterized gene), and forVEPH1(3q25), a gene implicated in brain development. We estimated an SNP-based heritability of 20-25% for DD, and observed significant associations of dyslexia risk with PGSs for attention deficit hyperactivity disorder (atp(T) = 0.05 in the training GWAS: OR = 1.23[1.16; 1.30] per standard deviation increase;p = 8 x 10(-13)), bipolar disorder (1.53[1.44; 1.63];p = 1 x 10(-43)), schizophrenia (1.36[1.28; 1.45];p = 4 x 10(-22)), psychiatric cross-disorder susceptibility (1.23[1.16; 1.30];p = 3 x 10(-12)), cortical thickness of the transverse temporal gyrus (0.90[0.86; 0.96];p = 5 x 10(-4)), educational attainment (0.86[0.82; 0.91];p = 2 x 10(-7)), and intelligence (0.72[0.68; 0.76];p = 9 x 10(-29)). This study suggests an important contribution of common genetic variants to dyslexia risk, and novel genomic overlaps with psychiatric conditions like bipolar disorder, schizophrenia, and cross-disorder susceptibility. Moreover, it revealed the presence of shared genetic foundations with a neural correlate previously implicated in dyslexia by neuroimaging evidence.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Reading-disability; Individual-differences; Susceptibility Gene; Molecular-genetics; Language; Comorbidity; Locus; Age; Schizophrenia; Intelligence
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2021
Prepublished im Jahr
2020
HGF-Berichtsjahr
2020
ISSN (print) / ISBN
1359-4184
e-ISSN
1476-5578
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 26,
Heft: ,
Seiten: 3004–3017
Artikelnummer: ,
Supplement: ,
Reihe
Verlag
Nature Publishing Group
Verlagsort
Campus, 4 Crinan St, London, N1 9xw, England
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
POF Topic(s)
30205 - Bioengineering and Digital Health
Forschungsfeld(er)
Genetics and Epidemiology
PSP-Element(e)
G-503200-001
Förderungen
Projekt DEAL
Fondazione Umberto Veronesi
Max Planck Society
Fraunhofer Society
Max Planck Society within the "Pakt fur Forschung und Innovation"
LIFE-Leipzig Research Center for Civilization Diseases - European Union
European Regional Development Fund (ERDF)
Free State of Saxony within the excellence initiative
Agence Nationale de la Recherche
European Commission
B.M.B.F. through the DIFUTURE consortium of the Medical Informatics Initiative Germany
European Union's Horizon 2020 Research and Innovation Programme (grant MultipleMS)
Wellcome Trust
Munich Cluster for Systems Neurology (SyNergy)
Copyright
Erfassungsdatum
2020-11-05